Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cidofovir
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Gilead Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Intravesical Cidofovir for Hemorrhagic Cystitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 22, 2013
Lead Product(s) : Cidofovir
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Gilead Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable